Hematologic Malignancy
Juvenile Xanthogranuloma
CI-CAN-00001049JXGExplore in graph →
HematologicNon-malignant2 active trials
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001049JXGExplore in graph →
Clinical trials
2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03155620 | Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) | active not recruiting | Phase 2 | 1,377 | National Cancer Institute (NCI)NIH | 4 | Jul 24, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Jul 24, 2026source: clinicaltrials